{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-020776","form_type":"8-K","ticker":"AVAH","cik":"0001832332","company_name":"Aveanna Healthcare Holdings, Inc.","filed_at":"2023-05-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.991492+00:00","generated_at":"2026-06-15T04:45:06.998746+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Aveanna Q1 net loss $32M vs prior year net income; revenue up 3.5% to $466.4M","bullets":["Net loss of $32.0M ($0.17 diluted loss) vs net income of $25.3M ($0.14 diluted EPS) in Q1 2022.","Adjusted EBITDA fell 25% to $28.5M (6.1% of revenue) from $38.0M (8.4%) in Q1 2022.","Revenue increased 3.5% to $466.4M, driven by Private Duty Services (+$22.8M) and Medical Solutions (+$3.6M), partially offset by Home Health & Hospice (-$10.5M).","Company affirms previously issued 2023 guidance; cash of $34.4M and undrawn revolver capacity of $162M as of April 1, 2023.","Free cash flow was $2.9M for Q1 2023; net cash from operations $7.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-020776","json":"https://secwatch.observer/filing/0000950170-23-020776.json","markdown":"https://secwatch.observer/filing/0000950170-23-020776.md","text":"https://secwatch.observer/filing/0000950170-23-020776.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832332/000095017023020776/0000950170-23-020776-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832332/000095017023020776/avah-20230511.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T04:45:06.998746+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9b43dd3dc463e250f16d0a1327f679da2db69d66","claim":"Aveanna Healthcare Holdings, Inc. reported first quarter 2023 (three-month period ended April 1, 2023) results: revenue $466.4 million, net income -$32.0 million, EPS -$0.17. Guidance reaffirmed.","evidence_excerpt":"in this Item 2.02. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS • Revenue increased 3.5% to $466.4 million, compared to Q1 2022 o Gross margin decreased 0.2% to $144.5 million, compared to Q1 2022 • Net loss was $32.0 million, compared to net income of $25.3 million in Q1 2022 o","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832332/000095017023020776/0000950170-23-020776-index.htm","confidence":0.98,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter 2023 (three-month period ended April 1, 2023)"},{"label":"Revenue","value":"$466.4 million"},{"label":"Net income","value":"-$32.0 million"},{"label":"EPS","value":"-$0.17"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}